Financing

US Treasury To Borrow $243B More This Spring: Dollar Climbs, Stocks Trim Gains
Boeing To Raise $10B Via Bond Sale Amid Credit Rating Downgrade - Will Investors Show Confidence?
Join Anthony Scaramucci In NYC For The Future Of Finance's Digital Era
Boeing To Raise $10B Via Bond Sale Amid Credit Rating Downgrade - Will Investors Show Confidence?
Join Anthony Scaramucci In NYC For The Future Of Finance's Digital Era
Emerging Tesla Challenger To Receive Another $1B From Vietnamese Billionaire: 'I Will Not Give Up On VinFast'
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?

Financing Recent News

Several Companies Under Elon Musk Billed Each Other Approximately $9 Million In Expenses, Raising Serious Questions About Corporate Governance
In a recent series of disclosures, Tesla Inc. (NASDAQ: TSLA) offered a glimpse into the financial relationships between Elon Musk's various enterprises, revealing a
What's The Net Worth Of These 4/20 Underdogs? Mid-Tier Cannabis Retailers & Cultivators Under The Spotlight
In the spotlight of Viridian Capital Advisors' latest Weekly Valuation Report are 16 Tier 2 and 3 U.S. cultivation and retail cannabis companies, each boasting market capitalizations between $10 million and $200 million.
WeWork's Former CEO Adam Neumann Proposes $600M Bid To Regain Control Of Bankrupt Company
Amid WeWork's bankruptcy woes, Adam Neumann seeks control with a $600 million offer through Flow. The battle intensifies as creditors weigh options amidst cash shortages and leadership skepticism.
EXCLUSIVE: Banking-Fit Means Your Cannabis Business Is At The 'Pinnacle Of Fitness,' Experts Explain At Benzinga Conference
Cannabis is a "competitive industry," and those looking to build their business in the space, should "embrace it." That's according to Kevin Hart, the founder and CEO of Green Check Verified, a leader in banking solutions for the cannabis industry. To get the much-needed capital, all you need to do is not be afraid of the competitive environment, he told those gathered at the Benzinga Cannabis Capital Conference in Florida on Tuesday. "There's access to financial and business services at your fingertips," Hart said, adding "you just have to be prepared to share some information." For Adam Stettner, the founder and CEO of FundCanna, who joined Hart and two other industry experts - Ryan Himmel, vice president and head of strategic partnerships at LeafLink and Sahar Ayinehsazian, a partner in Vicente LLP's Los Angeles office - on the stage at The Diplomat Beach Resort in Hollywood in a panel moderated by Jeanne M. Sullivan, chief investment officer at Arcview Ventures, that information is how the money will be used."
Small Group Of Hedge Funds Wields Dominance In US Treasury Market: 'A Concentration Of Vulnerability Has Built Up,' IMF Warns
The IMF is concerned about highly-leveraged hedge funds dominating the U.S. Treasury futures market, which could lead to systemic threats and instability in the global economy.
Carrier Global Invests In Strategic Thermal Labs For Data Center Cooling Solutions
Carrier Global teams up with Strategic Thermal Labs (STL) for liquid cooling innovation in data centers. Explore how this investment aligns with Carrier's commitment to cutting-edge climate solutions.
EXCLUSIVE: Focus On Selling Numbers, Not Dreams, That's What Makes Cannabis A Good Investment
"Not trying to always be the next unicorn is okay… it's actually great." That's according to Morgan Paxhia, a co-founder and managing director at Poseidon Investment Management. He told those gathered at the Benzinga Cannabis Capital Conference in Florida on Wednesday that selling a cannabis business and then building a new one from scratch is not a bad idea. "We need to see good investments being made, entrepreneurs being realistic about the valuations and building good companies… and not being afraid to hit the bit," Paxhia said. That, actually is a great way to attract investors' attention, he added. Paxhia joined three other experts, John Darwin, a managing partner of Luminous Capital, Brett Finkelstein, a managing partner of Skyvest Partners LP and Meris Kott, CEO of Shiny Health & Wellness Corp., on the stage at The Diplomat Beach Resort in Hollywood in a panel discussion moderated by Tom Zuber, a founder and the managing partner of Zuber Lawler, on what makes a company investable in the cannabis industry.
Why Children's Place Shares Are Skyrocketing Today
Children's Place Inc. experiences a significant uptick in shares following the announcement of a new financing agreement with majority shareholder Mithaq Capital SPC. The $90 million unsecured and subordinated term loan, expected to be funded by April 19, 2024, promises enhanced liquidity and favorable terms compared to previous arrangements.
It All Started With Cannabis: How This Innovative Manufacturing Software Firm Is Solving 'Real' Problem For Its Customers
Elevated Signals recently reported securing CA$7.9 million in Series A funding. The investment led by Yaletown Partners, with participation from Third Kind Venture Capital, WGD Capital, Colin Harris, Raiven Capital, and Pareto Holdings is slated to help the company expand and diversify in terms of the industries it serves. "Elevated Signals is solving a real problem for its customers and is aligned with larger trends in the market," Hans Knapp, general Partner and co-founder at Yaletown Partners, said recently.
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. Strategic alternatives explored. $120 million private placement. Acquisition expected mid-2024.
This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape
PharmaCielo revealed its plans to acquire cannabis operations in Thailand.On Wednesday, the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., said it has signed a binding letter of intent to enter a proposed transaction to acquire 100% of the issued and outstanding shares of Siam Ventures Corporation in exchange for common shares of PharmaCielo equaling to CA$3 million ($2.2 million).PharmaCielo also revealed it's undertaking a non-brokered private placement of 9,090,909 units at CA$0.2 per unit. Under the deal, the sum will be payable on closing by way of the issuance of 13,636,363 PharmaCielo Shares to the Siam Ventures' shareholders on a pro-rata basis.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers